Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8

Jaguar Health, Inc.

Issued 31,958 and 32,710 common shares to Streeterville on May 26 and June 1, 2026, respectively, in exchange for 3.72 and 4.2 Series Q Preferred shares.
Shares issued under Section 3(a)(9) exemption; no cash consideration exchanged.
Annual meeting reconvened June 2 but further adjourned to June 8 for stockholders to review proxy supplement filed May 29.
Record date remains April 15; stockholders who already voted need not take further action.

item 1.01 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Jaguar Health, Inc. entered into First Exchange Agreement with Streeterville Capital, LLC (effective 2026-05-26).

Action: entry
Agreement: equity purchase
Counterparty: Streeterville Capital, LLC
Effective: 2026-05-26

Exact text from the filing

On May 26, 2026, the Company entered into a privately negotiated exchange agreement with Streeterville (the “First Exchange Agreement”), pursuant to which the Company issued 31,958 shares (the “First Exchange Shares”) of the Company’s common stock, par value $0.0001 (the “Common Stock”) to Streeterville in exchange for an aggregate of 3.72 outstanding shares of Series Q Preferred Stock held by Streeterville (the “First Exchanged Preferred Shares”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Jaguar Health, Inc. entered into Second Exchange Agreement with Streeterville Capital, LLC (effective 2026-06-01).

Action: entry
Agreement: equity purchase
Counterparty: Streeterville Capital, LLC
Effective: 2026-06-01

Exact text from the filing

On June 1, 2026, the Company entered into another privately negotiated exchange agreement with Streeterville (the “Second Exchange Agreement”), pursuant to which the Company issued 32,710 shares (the “Second Exchange Shares”) of Common Stock to Streeterville in exchange for an aggregate of 4.2 outstanding shares of Series Q Preferred Stock held by Streeterville (the “Second Exchanged Preferred Shares”).

View on SEC.gov

82 material agreements filed in the last 30 days. Browse all material agreements →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-253506

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.